Analytical Data
-
基因名
TAF13
- Application
-
别名
TAF2K; TAFII18; Transcription Initiation Factor TFIID Subunit 13; Transcription initiation factor TFIID 18 kDa subunit
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q15543
-
表达区间
Met1~Ser124
-
分子量
20kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAF13, a subunit of the general transcription machinery, plays a critical role in the regulation of gene expression and is a component of the TFIID complex, which is essential for the initiation of transcription by RNA polymerase II. This protein has gained significant attention in recent years due to its involvement in various cellular processes, including transcriptional activation, cell differentiation, and response to stress. Studies have suggested that TAF13 may also have implications in oncogenesis and other diseases, making it a potential target for therapeutic interventions. The expression and functional analysis of recombinant TAF13 protein have been pivotal for understanding its structural and functional properties. Researchers utilize recombinant DNA technology to produce TAF13, allowing for detailed studies on its interactions with other transcription factors and co-regulators. Understanding the mechanisms by which TAF13 modulates transcription can provide insights into the complex regulatory networks that underlie gene expression and contribute to the development of diseases. As such, ongoing research into TAF13 and its recombinant forms aims to elucidate its role in biology and medicine, paving the way for novel approaches in disease treatment and gene therapy.
